Cell And Gene Therapy Contract Development And Manufacturing OrganizationCompanies

Q: How big is the Cell And Gene Therapy Contract Development And Manufacturing Organization Market?

The Cell And Gene Therapy Contract Development And Manufacturing Organization Market size is expected to reach USD 3.18 billion in 2024 and grow at a CAGR of 16.73% to reach USD 6.90 billion by 2028. Read More

Q: What is the current Cell And Gene Therapy Contract Development And Manufacturing Organization Market size?

In 2024, the Cell And Gene Therapy Contract Development And Manufacturing Organization Market size is expected to reach USD 3.18 billion. Read More

Q: Who are the key players in Cell And Gene Therapy Contract Development And Manufacturing Organization Market?

Catalent Inc, Lonza Group, Recipharm AB, Charles River Laboratories International Inc and Wuxi Advanced Therapies are the major companies operating in the Cell And Gene Therapy Contract Development And Manufacturing Organization Market. Read More

Q: Which is the fastest growing region in Cell And Gene Therapy Contract Development And Manufacturing Organization Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023-2029). Read More

Q: Which region has the biggest share in Cell And Gene Therapy Contract Development And Manufacturing Organization Market?

In 2023, the North America accounts for the largest market share in Cell And Gene Therapy Contract Development And Manufacturing Organization Market. Read More

Q: What years does this Cell And Gene Therapy Contract Development And Manufacturing Organization Market cover, and what was the market size in 2023?

In 2023, the Cell And Gene Therapy Contract Development And Manufacturing Organization Market size was estimated at USD 2.65 billion. The report covers the Cell And Gene Therapy Contract Development And Manufacturing Organization Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Cell And Gene Therapy Contract Development And Manufacturing Organization Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Cell And Gene Therapy Contract Development And Manufacturing OrganizationCompanies

This report lists the top Cell And Gene Therapy Contract Development And Manufacturing Organization companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Cell And Gene Therapy Contract Development And Manufacturing Organization industry.

Cell And Gene Therapy Contract Development And Manufacturing OrganizationTop Companies

Catalent
Lonza Group
Recipharm
Charles River Laboratories International Inc
Wuxi Advanced Therapies

*Disclaimer: Top companies sorted in no particular order

Cell And Gene Therapy Contract Development And Manufacturing Organization Market Major Players

Cell And Gene Therapy Contract Development And Manufacturing OrganizationMarket Concentration

Cell And Gene Therapy Contract Development And Manufacturing OrganizationCompany List

Catalent Inc
Lonza Group
Recipharm AB
Wuxi Advanced Therapies
Pfizer CentreOne
Charles River Laboratories International Inc
Patheon Inc
Almac Group
FUJIFILM Diosynth Biotechnologies
The Discovery Labs
BIOCENTRIQ
PCI Pharma Services

Specific to Cell And Gene Therapy Contract Development And Manufacturing Organization Market

Need More Details On Market Players And Competitors?

Download PDF

Cell And Gene Therapy Contract Development And Manufacturing OrganizationCompanies

Cell And Gene Therapy Contract Development And Manufacturing OrganizationTop Companies

Cell And Gene Therapy Contract Development And Manufacturing OrganizationMarket Concentration

Cell And Gene Therapy Contract Development And Manufacturing OrganizationCompany List

Cell And Gene Therapy Contract Development And Manufacturing Organization Market Report Snapshots

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)